Oneness Biotech Co Ltd Total Assets

Latest as of June 2026: NT$11.27 Billion TWD ≈ $354.95 Million USD

Oneness Biotech Co Ltd total assets. Based on the latest financial reports, Oneness Biotech Co Ltd (4743) holds total assets worth NT$11.27 Billion TWD (≈ $354.95 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Oneness Biotech Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Oneness Biotech Co Ltd (2009–2025)

Total assets of Oneness Biotech Co Ltd from 2009 to 2025. This chart illustrates how Oneness Biotech Co Ltd's total assets have evolved over time, based on quarterly financial data. See latest Oneness Biotech Co Ltd stock price today for real-time trading data and today's change.

Oneness Biotech Co Ltd - Asset Composition Analysis

Oneness Biotech Co Ltd Total Assets Breakdown (December 2025)

Oneness Biotech Co Ltd total assets breakdown as of December 2025. Oneness Biotech Co Ltd's total assets of NT$11.27 Billion consist of 52.5% current assets and 47.5% non-current assets.

Asset Category	Amount (TWD)	% of Total Assets
Cash & Equivalents	NT$0.00	14.1%
Accounts Receivable	NT$42.98 Million	0.4%
Inventory	NT$110.94 Million	1.0%
Property, Plant & Equipment	NT$0.00	0.0%
Intangible Assets	NT$933.83 Million	8.0%
Goodwill	NT$57.44 Million	0.5%

Asset Composition Trend (2009–2025)

This chart illustrates how Oneness Biotech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 4743 net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Oneness Biotech Co Ltd's current assets represent 52.5% of total assets in 2025, a decrease from 76.3% in 2009.
Cash Position: Cash and equivalents constituted 14.1% of total assets in 2025, down from 60.9% in 2009.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2009.
Asset Diversification: The largest asset category is intangible assets at 8.0% of total assets.

Oneness Biotech Co Ltd Competitors by Total Assets

Key competitors of Oneness Biotech Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$11.72 Billion
HLB Co. Ltd KQ:028300	Korea	₩925.44 Billion
Tubize-Fin BR:TUB	Belgium	€1.99 Billion
Shanghai Medicilon Inc SHG:688202	China	CN¥2.88 Billion
Blue Jet Healthcare Limited NSE:BLUEJET	India	Rs16.41 Billion
Hangzhou Biotest Biotech Co Ltd SHG:688767	China	CN¥2.49 Billion
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	China	CN¥725.73 Million
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	China	CN¥3.67 Billion

Oneness Biotech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	37.31	36.62	49.20
Quick Ratio	36.61	35.95	48.66
Cash Ratio	0.00	0.00	0.00
Working Capital	NT$5.62 Billion	NT$5.91 Billion	NT$7.43 Billion

Oneness Biotech Co Ltd - Advanced Valuation Insights

This section examines the relationship between Oneness Biotech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.13
Latest Market Cap to Assets Ratio	0.06
Asset Growth Rate (YoY)	-14.1%
Total Assets	NT$11.73 Billion
Market Capitalization	$691.90 Million USD

Valuation Analysis

Below Book Valuation: The market values Oneness Biotech Co Ltd's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Oneness Biotech Co Ltd's assets decreased by 14.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Oneness Biotech Co Ltd (2009–2025)

The table below shows the annual total assets of Oneness Biotech Co Ltd from 2009 to 2025.

Year	Total Assets	Change
2025-12-31	NT$11.73 Billion ≈ $369.67 Million	-14.10%
2024-12-31	NT$13.66 Billion ≈ $430.35 Million	-11.09%
2023-12-31	NT$15.36 Billion ≈ $484.04 Million	-1.39%
2022-12-31	NT$15.58 Billion ≈ $490.87 Million	-0.96%
2021-12-31	NT$15.73 Billion ≈ $495.61 Million	+2.25%
2020-12-31	NT$15.38 Billion ≈ $484.69 Million	+120.42%
2019-12-31	NT$6.98 Billion ≈ $219.90 Million	+198.86%
2018-12-31	NT$2.34 Billion ≈ $73.58 Million	-7.38%
2017-12-31	NT$2.52 Billion ≈ $79.44 Million	-1.34%
2016-12-31	NT$2.56 Billion ≈ $80.52 Million	-8.96%
2015-12-31	NT$2.81 Billion ≈ $88.45 Million	+39.36%
2014-12-31	NT$2.01 Billion ≈ $63.46 Million	-3.61%
2013-12-31	NT$2.09 Billion ≈ $65.84 Million	+46.55%
2012-12-31	NT$1.43 Billion ≈ $44.93 Million	+2.80%
2011-12-31	NT$1.39 Billion ≈ $43.71 Million	+25.23%
2010-12-31	NT$1.11 Billion ≈ $34.90 Million	-0.49%
2009-12-31	NT$1.11 Billion ≈ $35.07 Million	--

About Oneness Biotech Co Ltd

TWO:4743 Taiwan Biotechnology

Market Cap

$691.90 Million

NT$21.96 Billion TWD

Market Cap Rank

#10256 Global

#362 in Taiwan

Share Price

NT$45.80

Change (1 day)

-2.55%

52-Week Range

NT$41.15 - NT$74.80

All Time High

NT$395.32